Cargando…
MEDB-78. Unified rhombic lip origins of Group 3 and Group 4 medulloblastoma
Identification and characterization of lineage-specific beginnings of distinct medulloblastoma (MB) subgroups is a fundamental challenge in the field. Genetically engineered mouse models and cross-species transcriptomics have provided mounting evidence of discrete, subgroup-specific developmental or...
Autores principales: | Smith, Kyle, Bihannic, Laure, Gudenas, Brian, Gao, Qingsong, Haldipur, Parthiv, Tao, Ran, Iskusnykh, Igor, Chizhikov, Viktor, Scoggins, Matthew, Zhang, Silu, Edwards, Angela, Deng, Mei, Glass, Ian, Overman, Lynne, Millman, Jake, Sjoboen, Alexandria, Hadley, Jennifer, Mankad, Kshitij, Onar-Thomas, Arzu, Gajjar, Amar, Robinson, Giles, Aldinger, Kimberly, Hovestadt, Volker, Tillman, Heather, Orr, Brent, Patay, Zoltán, Millen, Kathleen, Northcott, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165102/ http://dx.doi.org/10.1093/neuonc/noac079.452 |
Ejemplares similares
-
MEDB-82. Exploring cell-cell communication networks in medulloblastoma using single-cell genomics
por: Gabler, Lisa, et al.
Publicado: (2022) -
MEDB-69. Clinical and molecular meta-analysis of three major medulloblastoma clinical trials (ACNS0331, SJMB03, ACNS0332) uncovers novel strategies to improve risk-stratified therapy
por: Smith, Kyle S, et al.
Publicado: (2022) -
MEDB-74. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
por: Northcott, Paul, et al.
Publicado: (2022) -
MEDB-29. Application of Rotterdam Post-Operative Cerebellar Mutism Syndrome Prediction Model to Patients Operated for Medulloblastoma in a Single Institution
por: Khan, Raja, et al.
Publicado: (2022) -
MEDB-87. Transcriptome-driven drug repurposing in group 3 medulloblastoma
por: Doss, David, et al.
Publicado: (2022)